1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Maryland >
  6. Clywedog Therapeutics Acquires Avidea Technologies

M&A Deal Summary

Clywedog Therapeutics Acquires Avidea Technologies

On December 13, 2021, Clywedog Therapeutics acquired life science company Avidea Technologies for 40M USD

Acquisition Highlights
  • This is Clywedog Therapeutics’ 1st transaction in the Life Science sector.
  • This is Clywedog Therapeutics’ largest (disclosed) transaction.
  • This is Clywedog Therapeutics’ 1st transaction in the United States.
  • This is Clywedog Therapeutics’ 1st transaction in Maryland.

M&A Deal Summary
Date 2021-12-13
Target Avidea Technologies
Sector Life Science
Buyer(s) Clywedog Therapeutics
Deal Type Add-on Acquisition
Deal Value 40M USD

Target

Avidea Technologies

Baltimore, Maryland, United States
Avidea Technologies is a biotechnology company that is advancing the next generation of safer and more effective T cell immunotherapies for treating cancer, infections, and autoimmune diseases. Avidea Technologies is based in Baltimore, Maryland.

Search 215,058 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Clywedog Therapeutics

Didcot, United Kingdom
Category Company
Founded 2016
Sector Life Science
Employees105
Revenue 15M USD (2024)
DESCRIPTION

Clywedog Therapeutics is a clinical-stage biopharmaceutical company developing novel immunotherapies that guide T cells to overcome autoimmunity and inflammatory diseases. Clywedog Therapeutics was founded in 2016 and is based in Didcot, United Kingdom.

DEAL STATS #
Overall 1 of 2
Sector: Life Science M&A 1 of 2
Type: Add-on Acquisition M&A Deals 1 of 1
State: Maryland M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2021 M&A 1 of 1
Size (of disclosed) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2025-09-30 Clywedog Therapeutics

Altrincham, United Kingdom

Clywedog Therapeutics is a clinical-stage biopharmaceutical company poised for growth in the public markets, developing advanced therapies for metabolic and autoimmune diseases. Clywedog Therapeutics is based in Altrincham, United Kingdom.

Buy -
Mergr

Solution for

Product

Company

Legal